Latest information on COVID-19

Division of Infectious Diseases & Geographic Medicine

in the Department of Medicine

Division News and Recognition

  • Sad news for the ID community. Drs. Katzenstein and Remington obituaries here.
  • August 2021: Congratulations to Makeda Robinson, MD, PhD, postdoctoral research fellow in infectious diseases, who recently received a Harold Amos Career Development Award from the Robert Wood Johnson Foundation.
  • August 2021:  Welcome to our new Clinical Assistant Professors, Drs. Jessica Ferguson and Daisuke Furukawa, and Dr. Michael Kozal, Med-ID's newest University Faculty Medical Line Professor.
  • July 2021: Welcome Dr. Jorge Salinas, who will be Co-director of the Hospital Epidemiology track, to the ID faculty, and welcome new ID Fellowship and Transplant ID Fellowship trainees!
  • April 2021: Dr. Brian Blackburn is the recipient of two accomplishments: first the promotion to Clinical Professor for his outstanding teaching, and second the 2021 Alwin C. Rambar-James B.D. Mark Award for Excellence in patient care. Congrats!
  • March 2021:  Dr. Catherine Blish's promotion to Professor recognizes her many scientific and mentoring accomplishments. Kudos!
  • May 2020: Congrats to Drs. Phil Grant, Aruna Subramanian and Drs. Mark Holodniy and Aarthi Chary on their New England Journal of Medicine papers showing benefit of RDV in patients with COVID-19
  • May 2020: The IDSA Foundation features Dr. Lucy Tompkins as their second 2020 Woman of ID. Read about her contributions here.

Read some articles in Division News.

The Stanford ID team won the BugBowl trivia game during the IDSA IDWeek conference in San Francisco October 2018.

In the Press

Read additional mentions in our "In the Press" page

Our Infectious Diseases Faculty on Coronavirus


  • Dr. Benjamin Pinsky talks about the buzz test that sacrifices speed for accuracy.

KTVU Fox 2 | July 1, 2020: Stanford researchers to start clinical trial of COVID-19 drug in pill form

  • Dr. Aruna Subramanian is hopeful the results for a Favipiravir clinical trial will lessen the effects of the coronavirus.

The Washington Post | June 26, 2020: What is pool testing and how does it work?

  • Dr. Benjamin Pinsky's lab did pool testing before a coronavirus test was available, proving it was not yet widespread December through February.

NBC Bay Area | June 15, 2020: Governor, Bay Area Health Experts Urge People to Wear Face Coverings

  • Dr. Dean Winslow encourages mask wearing when social distancing is not an option.

SF Chronicle | May 14, 2020: Bay Area doctors prepare for coronavirus in looming flu season

  • Dr. David Relman advises needed strategies for a resurgence of cases and a potentially much deadlier situation in the winter.

SF Chronicle | April 29, 2020: Gilead drug remdesivir shows promise in two coronavirus trials

  • Dr. Aruna Subramanian discusses the promising results to the experimental coronavirus drug remdesivir.

Pop Sugar | April 28, 2020: There's an Emerging, Promising Link Between Exercise and Your Immune Health

  • Dr. Aruna Subramanian and Dr. Dean Winslow weigh in on the exercise benefits on psychological and immune health.

ABC News | April 17, 2020: Scientists have strong evidence coronavirus originated naturally

  • Dr. Bob Shafer discusses the origins of the novel coronavirus. 

The New Yorker | April 6, 2020: The Quest for a Pandemic Pill

  • Dr. Shirit Einav talks about the host-targeted drug approach.

WSJ | March 24, 2020: Is the Coronavirus as Deadly as They Say?

  • In this op-ed, Dr. Eran Bendavid estimates the Covid-19 fatality rate may be too high by orders of magnitude.

Live Science | March 4, 2020: These 5 mistakes could worsen the coronavirus outbreak

  • Dr. Stan Deresinski cautions why these mistakes are not only costly to yourself but others.

KTVU Fox 2 | March 2, 2020: More coronavirus cases in Santa Clara County; total is now at nine

  • Dr. Aruna Subramanian informs the importance of taking precautions, such as frequent hand-washing and social distancing.

NBC Bay Area | Feb 28, 2020: Do You Really Need a Face Mask to Avoid Coronavirus Spread?

  • Dr. Stan Deresinski responds to questions regarding a highly-coveted, new shopping item—the face mask.

CBS SF Bay Area | Feb 26, 2020: San Francisco Declares Emergency Over ‘Growing Likelihood’ Of Coronavirus Cases

  • Dr. Eran Bendavid forwarns everything he has seen thus far suggests the virus will spread in the U.S. 

Bloomberg | Feb 16, 2020: Fears of Global Coronavirus Contagion as 3,000 Cruise Passengers Go Home

  • Dr. Stan Deresinski warns there is a possibility anyone infected and asymptomatic could start a chain of infection wherever they return.

Vox | Feb. 13, 2020: “No handshakes, please”: The tech industry is terrified of the coronavirus

  • Dr. Stan Deresinski explains transmission is primarily through respiratory droplets with handshakes being secondary, yet there is always a risk.

ABC7 | Feb. 4, 2020: Coronavirus: Can the outbreak affect pets? Expert explains

  • For those worrying about if their pets can catch the coronavirus, Dr. Eran Bendavid says it's "exceptionally unlikely."



Read further press on the Interferon-Lambda clinical trial

You’re Missing Microbes. But Is ‘Rewilding’ the Way to Get Them Back?

The science behind the idea of restoring the intestinal microbiome to an ancestral state is shaky, skeptics say, and in some cases unethical.

Written by Gina Kolata on July 19, 2021

As the sun set in Tanzania on a September evening in 2014, Jeff Leach inserted a turkey baster filled with another man’s feces into his rectum and squeezed the bulb. The feces, he said, came from a hunter-gatherer who was a member of the Hadza people and lived nearby.

Mr. Leach said he was trying to “rewild” his microbiome, giving himself microbes that can protect against chronic and autoimmune diseases that plague people in Western societies — including obesity, diabetes and irritable bowel syndrome. The theory relies on the idea that people like the Hadza have diets and lifestyles that are more like those of ancient populations, and harbor such microbes. Channeling tropes that could have come from colonial era literature, Mr. Leach said the man he got the feces from “had only recently dined on zebra and monkey.”

Rewilding the microbiome is now a rising area of study — combining microbiology, epidemiology and anthropology — with big money at stake. Finch Therapeutics, a microbiome start-up founded by scientists at M.I.T., recently raised $128 million in an I.P.O., even though it has no product on the market.

But “rewilding” is hotly debated, both as a medical and ethical enterprise. Critics ask basic questions about the validity of the science itself: How do you know what microbes people had in their guts before industrialization, and why do you think people were healthier then? If you decide to add some back, why would they succeed in a colon already teeming with trillions of microbes all fighting for a niche?

Our division's events and didactics

Patient Care Teams/Clinics

Transportation Resources

Bay Area Transit

Parking Map

Marguerite shuttle 
(use the X or MC lines from Palo Alto Transit Center)



Directions to the ID Division

300 Pasteur Dr., Lane L134

Loading Map...

Division of Infectious Diseases: 300 Pasteur Dr., Lane Bldg 134

300 Pasteur Drive, L-134
Stanford CA, 94305
Get Directions